Larson Financial Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537 | Hold |
244
| – | – | ﹤0.01% | 2814 |
|
|
2025
Q1 | $283 | Hold |
244
| – | – | ﹤0.01% | 2692 |
|
|
2024
Q4 | $310 | Hold |
244
| – | – | ﹤0.01% | 2313 |
|
|
2024
Q3 | $832 | Hold |
244
| – | – | ﹤0.01% | 2006 |
|
|
2024
Q2 | $1.14K | Sell |
244
-500
| -67% | -$2.33K | ﹤0.01% | 1675 |
|
|
2024
Q1 | $5.52K | Buy |
744
+500
| +205% | +$3.71K | ﹤0.01% | 1171 |
|
|
2023
Q4 | $2.47K | Hold |
244
| – | – | ﹤0.01% | 1331 |
|
|
2023
Q3 | $1.9K | Hold |
244
| – | – | ﹤0.01% | 1369 |
|
|
2023
Q2 | $2.01K | Hold |
244
| – | – | ﹤0.01% | 1263 |
|
|
2023
Q1 | $1.77K | Hold |
244
| – | – | ﹤0.01% | 1261 |
|
|
2022
Q4 | $2.16K | Hold |
244
| – | – | ﹤0.01% | 1179 |
|
|
2022
Q3 | $3K | Hold |
244
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q2 | $3K | Hold |
244
| – | – | ﹤0.01% | 950 |
|
|
2022
Q1 | $5K | Hold |
244
| – | – | ﹤0.01% | 786 |
|
|
2021
Q4 | $6K | Hold |
244
| – | – | ﹤0.01% | 773 |
|
|
2021
Q3 | $10K | Hold |
244
| – | – | ﹤0.01% | 588 |
|
|
2021
Q2 | $14K | Hold |
244
| – | – | ﹤0.01% | 494 |
|
|
2021
Q1 | $10K | Buy |
244
+100
| +69% | +$4.1K | ﹤0.01% | 539 |
|
|
2020
Q4 | $10K | Hold |
144
| – | – | ﹤0.01% | 490 |
|
|
2020
Q3 | $4K | Buy |
+144
| New | +$4K | ﹤0.01% | 543 |
|
|
2020
Q1 | – | Sell |
-500
| Closed | -$15K | – | 559 |
|
|
2019
Q4 | $15K | Buy |
+500
| New | +$15K | 0.01% | 258 |
|